A fusion protein targeting the vascular endothelial growth factor receptor I (VEGFR-1)

被引:0
|
作者
Bai, XY
Ni, JF
Lü, AG
Wu, WF
Niu, RF
机构
[1] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China
[2] Chinese Acad Sci, Grad Sch, Beijing 100016, Peoples R China
[3] Tianjin Med Univ, Canc Hosp, Tianjin 300060, Peoples R China
关键词
diphtheria toxin; vascular endothelial growth factor (VEGF); vascular endothelial growth factor receptor-1; fusion protein;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diphtheria toxin is an exotoxin secreted by Corynebacterium diphtheriae that has been lysogenized by P bacteriophage that carries the DT gene. It blocks protein synthesis and kills the target eukaryotic cell. The R82A, K84A, H86A mutant of vascular endothelial growth factor (VEGF) specially binds its receptor 1 (VEGFR-1) that is expressed highly on surface of tumor blood vessel. DT genomic DNA was extracted first and then the gene that coding the T domain and C domain of DT (DT391) were amplified. The R82A, K84A, H86A mutant were introduced to VEGF by site-directed mutagenesis. Then a VEGFR-I targeting fusion protein, DT391-mVEGF, was constructed by substituting the receptor binding domain of DT with the VEGF mutant which shows high affinity to a receptor expressed on tumor vascular. With DT391, a protein without the mVEGF domain of DT391-mVEGF, as a negative control in cytotoxicity assay, the hybrid protein DT391-mVEGF showed an inhibition to the growth of VEGFR-1 positive tumor cell.
引用
收藏
页码:365 / 370
页数:6
相关论文
共 13 条
  • [1] Arora N, 1999, CANCER RES, V59, P183
  • [2] Shiga-like toxin-VEGF fusion proteins are selectively cytotoxic to endothelial cells overexpressing VEGFR-2
    Backer, MV
    Budker, VG
    Backer, JM
    [J]. JOURNAL OF CONTROLLED RELEASE, 2001, 74 (1-3) : 349 - 355
  • [3] Crystal structure of nucleotide-free diphtheria toxin
    Bell, CE
    Eisenberg, D
    [J]. BIOCHEMISTRY, 1997, 36 (03) : 481 - 488
  • [4] BOLET C, 1991, NUCLEIC ACIDS RES, V8, P1955
  • [5] Angiogenesis in cancer and other diseases
    Carmeliet, P
    Jain, RK
    [J]. NATURE, 2000, 407 (6801) : 249 - 257
  • [6] Chai Ying-Shuang, 2004, Sheng Wu Gong Cheng Xue Bao, V20, P192
  • [7] Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors - Generation of receptor-selective VEGF variants by site-directed mutagenesis
    Keyt, BA
    Nguyen, HV
    Berleau, LT
    Duarte, CM
    Park, J
    Chen, H
    Ferrara, N
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (10) : 5638 - 5646
  • [8] A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/FlK-1 receptor and carries a potent mitotic activity without heparin-binding domain
    Ogawa, S
    Oku, A
    Sawano, A
    Yamaguchi, S
    Yazaki, Y
    Shibuya, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (47) : 31273 - 31282
  • [9] Olson TA, 1997, INT J CANCER, V73, P865
  • [10] Extension of juxtamembrane domain of diphtheria toxin receptor arrests translocation of diphtheria toxin fragment A into cytosol
    Takahashi, T
    Umata, T
    Mekada, E
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 281 (03) : 690 - 696